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Secretome Analysis of Hypoxia-Induced 3T3-L1 Adipocytes
Uncovers Novel Proteins Potentially Involved in Obesity
Anna Elisa Laria, Sebastiano Messineo, Biagio Arcidiacono, Mariaconcetta Varano,
Eusebio Chiefari, Robert K. Semple, Nuno Rocha, Diego Russo, Giovanni Cuda,
Marco Gaspari,* Antonio Brunetti,* and Daniela P. Foti*
In the obese state, as adipose tissue expands, adipocytes become hypoxic and
dysfunctional, leading to changes in the pattern of adipocyte-secreted
proteins. To better understand the role of hypoxia in the mechanisms linked to
obesity, we comparatively analyzed the secretome of murine diﬀerentiated
3T3-L1 adipocytes exposed to normoxia or hypoxia for 24 h. Proteins secreted
into the culture media were precipitated by trichloroacetic acid and then
digested with trypsin. The peptides were labeled with dimethyl labeling and
analyzed by reversed phase nanoscale liquid chromatography coupled to a
quadrupole Orbitrap mass spectrometer. From a total of 1508 identiﬁed
proteins, 109 were diﬀerentially regulated, of which 108 were genuinely
secreted. Factors signiﬁcantly downregulated in hypoxic conditions included
adiponectin, a known adipokine implicated in metabolic processes, as well as
thrombospondin-1 and -2, and matrix metalloproteinase-11, all
multifunctional proteins involved in extracellular matrix (ECM) homeostasis.
Findings were validated by Western blot analysis. Expression studies of the
relative genes were performed in parallel experiments in vitro, in diﬀerentiated
3T3-L1 adipocytes, and in vivo, in fat tissues from obese versus lean mice.
Our observations are compatible with the concept that hypoxia may be an
early trigger for both adipose cell dysfunction and ECM remodeling.
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1. Introduction
Obesity predisposes to the risk of type 2
diabetes mellitus, cardiovascular disease,
and even some types of tumors. Its
alarming prevalence has become a seri-
ous health problem in many countries
in the world.[1,2] Studies in the last two
decades have strongly implemented
our knowledge about the biological role
of adipose tissue, demonstrating that,
besides storing lipids, this tissue actively
participates in the regulation of impor-
tant physiological processes, such as
energy balance and glucose homeostasis,
by secreting a variety of biomolecules
collectively termed as adipokines, whose
discovery and characterization are still
ongoing.[3,4] Many studies have demon-
strated that the adipose cell becomes
dysfunctional in the obese state, and, as
a consequence, the proﬁle of the secreted
adipokines changes towards an unfa-
vorable pattern, that promotes insulin
resistance, inﬂammation, endothelial
dysfunction and thrombophilia.[5–7] Re-
versibility of obesity-related conditions is
proved by changes in the biochemical proﬁle following weight
loss.[8]
Several studies support the concept that adipose tissue hy-
poxia (ATH) is an important trigger of adipose cell dysfunction
in obesity. Although evidences are stronger in animal models
than in humans, ATH in obesity is demonstrated by a series
of mechanisms, including a reduction in adipose tissue blood
ﬂow, low availability of oxygen for clusters of adipose cells dis-
tant from the vasculature, reduced oxygen consumption, as well
as mitochondrial dysfunction in adipose cells.[9–11] Thus, investi-
gations aimed at identifying molecules induced or repressed by
hypoxia in appropriate experimental models may be important
to better understand the pathophysiological events linked to obe-
sity. While the hypoxia-inducible factors (HIFs) have been recog-
nized as the main molecular regulators of the cellular response
to hypoxia,[12,13] many studies employing traditional molecu-
lar biology techniques have identiﬁed hypoxia target genes and
gene products secreted by adipose cells, such as visfatin, vascu-
lar endothelial growth factor (VEGF), leptin, adiponectin, and
other adipokines.[9,14–17] On the other hand, animal transgenic
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Signiﬁcance of the study
Obesity is amajor health problemworldwide, inwhich adi-
pose tissue expansion anddysfunctionpredispose to the risk
of several illnesses, including type 2diabetesmellitus and car-
diovascular disease. Ashypoxia has emerged as an early factor
that triggers adipose tissuedysfunction in obesity, diﬀerentially
expressedproteinswere analyzed, by LC/MS/MS, in the se-
cretome fromhypoxic versusnormoxic in vitro 3T3-L1murine
diﬀerentiated adipose cells as a surrogate biological system for
adipose cell function/dysfunction studies. Taken together, in
hypoxia, the identiﬁedprotein changeswere functionally coher-
entwith extracellularmatrix remodeling. Also, novel regulated
proteins associatedwith the adipocyte secretomehavebeen
identiﬁed for the ﬁrst time, and their roles deserve further inves-
tigation. Resultswere further validatedbyWestern blot analysis
andgene expression studies in 3T3-L1 cells, andnotably, to
someextent, also in adipose tissues fromobese vs leanmice.
In conclusion, the identiﬁedproteins in this studymaybe in-
volved in early changes linked to adipose cell dysfunction, and
mayhave thepotential to be relevant to thepathophysiology of
humanobesity.
models constitutively overexpressing HIF-1α have contributed to
the deﬁnition of hypoxia-mediated eﬀects on proteins involved in
insulin resistance and adipose tissue ﬁbrosis.[18]
Proteomic technology has emerged as a powerful, and useful
tool to identify key factors in the adipose proteome, and gain fur-
ther insights into adipose cell biology.[19–21] In this context, by us-
ing diﬀerent proteomic proﬁling approaches, the analysis of the
adipose secretome has been adopted to analyze large sets of se-
creted proteins.[19–24] Investigations aimed at understanding the
diﬀerential expression of the adipocyte secretome after cell stim-
ulation with insulin, insulin sensitizers, or other agents have
been already successfully undertaken,[25–27] as well as studies
analyzing the secretome from human Simpson-Golabi-Behmel
syndrome (SGBS) preadipocytes and adipocytes, exposed to the
hypoxia-mimetic cobalt chloride (CoCl2),[28] and exosomes from
murine 3T3-L1 adipocytes under hypoxic conditions.[29]
Murine 3T3-L1 adipocytes are the most widely used cells
for studying adipogenesis and obesity-related characteristics[30];
however, the eﬀects of hypoxia on the whole secretome of 3T3-
L1 adipocytes have not been investigated yet by a proteomic ap-
proach. To better understand the dynamic changes aﬀecting adi-
pose tissue secretion during hypoxia as a paradigm of the obese
state, in the present work we comparatively analyzed the secre-
tome of 3T3-L1 adipocytes, exposed to either normoxia or hy-
poxia. By using reversed-phase nanoscale liquid chromatography
coupled to a quadrupole Orbitrap mass spectrometer, we identi-
ﬁed 108 genuinely secreted, diﬀerentially expressed proteins, out
of which only 28 where previously described by similar studies
in the secretome from human and murine adipocytes.[28,29] Alto-
gether, the role of the identiﬁed proteins appears to be important
in the extracellular matrix (ECM) remodeling and relevant to adi-
pose tissue dysfunction.
2. Experimental Section
2.1. Cell Culture, Viability, and Functional Tests in Normoxia and
Hypoxia
3T3-L1 preadipocytes were grown and diﬀerentiated into
adipocytes as previously described.[31] Once complete diﬀeren-
tiation was reached, cells were maintained in medium without
serum and antibiotics, in either normoxic (21% O2) or hypoxic
(2% O2) conditions for 24 h. Cell viability in serum-free me-
dia was tested by 3-(4,5-dimethythiazol-. 2-yl)-2,5-diphenyl tetra-
zolium bromide (MTT) assay.[32] Lipid droplet accumulation in
normoxic and hypoxic 3T3-L1 adipocytes was tested by red oil
O staining, as reported by the manufacturer (Bio-Optica, Milan,
Italy). Tests are detailed in Supporting Information A.
2.2. Immunoblotting
Western blot (WB) analyses were performed with standard tech-
niques using nuclear extracts obtained from diﬀerentiated 3T3-
L1 cells, and murine fat tissues, as previously described.[33] Pro-
teins from 3T3-L1 secretome were loaded after trichloroacetic
acid (TCA) precipitation. Antibodies used and densitometric
analysis are reported in Supporting Information A.
2.3. Collection and Processing of Conditioned Media
Conditioned media from 3T3-L1 adipocytes, in either normoxic
or hypoxic condition for 24 h, were collected and ﬁltered through
a 0.45 μM ﬁlter to remove cell debris. To concentrate samples,
10% v/v TCA was added and proteins precipitated overnight at
4 °C. Samples were centrifuged at 14 000 rpm for 30 min and
the supernatants removed. After two washes with 200 μL cooled
ether and 200μL cooled acetone and centrifugation at 14 000 rpm
for 10min, 4 °C, supernatants were removed and dry samples re-
suspended in 50μLUrea Buﬀer (6M urea, 100mMTris, pH 8.0).
The ﬁnal protein concentration was measured using the Micro
Bicinchoninic Acid (BCA) Protein Assay (G-Biosciences).
2.4. Trypsin Digestion, Dimethyl Labeling, and Peptide
Fractionation
100μg of each sample were reduced with 5μL of 100mM dithio-
threitol (DTT) for 1 h at 37 °C, then alkylated with 6 μL of 24 mM
iodoacetamide (IAA) by incubating 1 h at 37 °C in the dark to pro-
tect reduced cysteines. Finally, the excess of IAAwas quenched by
adding 1μL of 2mMDTT and the reaction allowed to proceed for
20min at 37 °C. Solution was brought to a volume of 150μL with
HPLC-grade water and protein digestion performed overnight
by adding 50:1 (w/w) trypsin (protein:enzyme ratio). After di-
gestion, puriﬁcation of 15 μg of peptides from each sample by
C18 StageTips (EmporeTM-3M, C18 Extraction Disks) was per-
formed as previously described.[34] Peptides were eluted in 20 μL
of 50% acetonitrile and 0.1% formic acid and subsequently dried
Proteomics 2018, 18, 1700260 C© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700260 (2 of 10)
www.advancedsciencenews.com www.proteomics-journal.com
by a speed vacuum system. For quantitative mass spectrometry
analysis, dried samples were resuspended in 100 μL of 100 mM
tetraethylammonium bicarbonate (TEAB). 4 μL of 4% CH2O,
and 4 μL of 4% CD2O were added in order to label the samples
with the “light” (L) form, and with the “medium” (M) form of the
reagent, respectively. Four microliters of 0.6 M NaBH3CN were
added to L and M labeled samples before incubating for 1 h at
room temperature. The reaction was stopped by adding 16 μL
of 1% w/v ammonia solution. The analysis was performed in
biological duplicates. Each biological replicate was analyzed in
forward/reverse labeling mode (L:M and M:L). Before perform-
ing LC-MS/MS analysis, samples were mixed in pairs and pu-
riﬁed by C18 StageTips. Samples were puriﬁed and fractionated
by Strong Cation Exchange Chromatography (SCX) using extrac-
tion disks (Empore Cation 47mmExtraction Disks) as previously
described.[34] Six fractions were obtained by eluting samples at six
diﬀerent concentrations of ammonium acetate (50, 75, 100, 150,
250, and 500 mm). All six eluents contained 20% acetonitrile v/v
and 0.5% acetic acid v/v, except the last eluent, to which no acid
was added.
2.5. Mass Spectrometry and Data Analysis
Peptides were analyzed by reversed phase nanoscale liquid chro-
matography coupled to a quadrupoleOrbitrapmass spectrometer
(Thermo Fisher Scientiﬁc, Odense, Denmark).
Peptides were analyzed by a nanoLC capillary column (75 μm
i.d., length: 10 cm), packed with 3 μm C18 silica particles
(Dr. Maisch GmbH, Ammerbuch, Germany). Peptides were
loaded at 500 nL min−1 into the analytical column. Mobile phase
A was 0.1% formic acid, 2% acetonitrile, whereas mobile phase
B was 0.1% formic acid, 80% acetonitrile. The ﬂow rate was
300 nL min−1, and peptides were separated using a linear gradi-
ent of phase B from 8 to 35% in 55 min, and from 30 to 100% in
8 min. MS detection was performed on a Q-Exactive quadrupole
ion trap-Orbitrap mass spectrometer (Thermo Fisher Scientiﬁc,
Bremen, Germany). MS acquisition was performed in positive
ionization mode, by nanoelectrospray (nESI). The acquisition of
product ion mass spectra was done using the data-dependent ac-
quisition (DDA)modes. Full scanm/z range was 350–1800. DDA
was performed by using a top-12 method with resolution for full
MS of 70 000 and of 17 500 for MS/MS; AGC target was 106
for full MS and 105 for MS/MS; maximum injection time (ms)
was 50 ms for full MS, and 60 ms for MS/MS. Mass window for
precursor ion isolation was 1.6 m/z. Normalized Collision en-
ergy was 25. Dynamic exclusion was 30 s. Raw data were pro-
cessed for protein identiﬁcation and quantitation using the soft-
ware MaxQuant version 1.6.0.16,[35] using default parameters for
dimethyl labeled peptides, with the following exceptions: mini-
mum peak length: 3; minimum ratio count: 1 unique + razor
peptide. Tandem mass spectrometry data were searched by the
Andromeda search engine by querying theMouse Reference Pro-
teome Database (51 949 sequences, accessed on October 2017).
Forward/reverse experiments for each biological replicate were
searched as a single experiment in MaxQuant.
2.6. Animal Studies
Male C57BL/6JolaHsd mice were subjected to either nor-
mocaloric diet (n = 5) or high-fat diet (n = 4) for 18 weeks. Fur-
ther details are described in Supporting Information A. After eu-
thanasia by cervical dislocation, epididimal fat pads were excised
and immediately stored in liquid nitrogen until use for RNA and
protein extractions. The study was carried out in accordance with
the Italian rules (D.M. 116/92) and the Directive 2010/63/EU of
the European Parliament and of the European Council regarding
the protection of animals used for scientiﬁc purposes, and with
the permission of national authorities (MIN.SAL. N°114/2006-A
08/09/2006).
2.7. RNA Extraction, cDNA Synthesis, and Quantitative
Real-Time PCR
Total RNA was extracted from adipocytes and from visceral fat
tissues, as previously described.[36] Reverse transcription was per-
formed from 1 μg RNA (High-Capacity cDNA Reverse Tran-
scription Kits, Applied Biosystems, Thermo Fisher Scientiﬁc,
Bremen, Germany). Primers used were designed according to se-
quences from the Gene Bank Database and are described in Sup-
porting Information A. Quantitative real-time PCR (q-RT PCR)
was performed by a real-time thermocycler (Eppendorf Master-
cycler ep realplex ES), as previously described.[37] SYBR Green
ﬂuorescence was measured (Real Master Mix Sybr Rox 5 prime,
Eppendorf, Hamburg, Germany) and relative quantiﬁcation was
made using RPS9 to normalize the expression of the genes
of interest. PCR reactions were repeated for three biological
replicates.
2.8. Statistical and Bioinformatic Analysis
The data matrix produced by MaxQuant was uploaded in
Perseus, version 1.6.07[35] for statistical analysis. After remov-
ing hits associated to contaminants and reverse database, data
were log2-transformed. Protein hits quantiﬁed in at least three
biological replicates were retained. After data normalization
on protein median, a one-sample t-test was performed. Pro-
teins whose average fold change was either > 2 or < 0.5,
with associated p-value < 0.05, were considered diﬀerentially
expressed.
Functional annotation of the signiﬁcantly altered proteins was
achieved using DAVID (Database for Annotation, Visualization
and Integrated Discovery) Bioinformatics Resources 6.7.[38] Sta-
tistical signiﬁcance was expressed as p-values after Benjamini–
Hochberg correction.
Statistical analysis of expression studies was carried out us-
ing GraphPad software. The analysis of gene expression was per-
formed using the Mann–Whitney test. Diﬀerences were consid-
ered signiﬁcant when p < 0.05.
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Figure 1. Induction of hypoxia in diﬀerentiated 3T3-L1 cells. A) Cells were
incubated under normoxia or hypoxia (O2, 2%) for 24 h, and Western blot
(WB) for HIF-1α was carried out from nuclear protein extracts; lamin A/C,
control of protein loading. B) q-RT PCR for VEGF gene expression was per-
formed in parallel experiments. Data are means ± SEM of three indepen-
dent experiments. *p < 0.001 versus normoxia. C) Microscopic images of
3T3-L1 adipocytes, before (T0) and after 24 h of normoxia and hypoxia,
and relative MTT assay, D) after 24 h. E) Red Oil O staining of 3T3-L1
adipocytes and extracted solution after 24 h normoxia or hypoxia, and its
absorbance (Abs), (F) at 490 nm. In (D) and (F), data are expressed as
relative fold change compared to normoxia, which is assigned an arbitrary
value of 1; data are means ± SEM of three independent assays. NS = not
signiﬁcant.
3. Results
3.1. Conditioned Media and MS Analysis Work Flow
To verify the appropriateness of the experimental conditions, dif-
ferentiated 3T3-L1 adipocytes were incubated under normoxia
or hypoxia for 24 h. Hypoxic conditions were conﬁrmed by in-
creased protein levels ofHIF-1α, the hypoxia-induciblemonomer
of HIF-1, and by increased gene expression of VEGF, a known
HIF-1 target gene (Figure 1A,B). No signiﬁcant diﬀerences were
detectable in cell viability in normoxia versus hypoxia, as mea-
sured by MTT assay (Figure C and D), and in mature adipocyte
functions, such as lipid droplet accumulation, as visualized by
red oil O staining (Figure 1E,F).
After 24 h, conditioned media from normoxic or hypoxic 3T3-
L1 adipocytes, obtained in biological quadruplicates, were col-
lected, and proteins precipitated by TCA, reduced with DTT, alky-
lated by IAA, and ﬁnally digested by trypsin. Trypsin-digested
peptides were chemically labeled by “stable isotope dimethyl la-
beling,” and samples analyzed by nLC-MS/MS.Whole secretome
analysis led to the identiﬁcation of 1508 proteins quantiﬁed in at
least three of the four biological replicates (Supporting Informa-
tion, Table 1).
Based on gene ontology, proteins classiﬁed as “extracellular
region,” “extracellular space,” and “extracellular exosome” were
considered genuinely secreted (Supporting Information B). Eight
hundred and thirty-nine out of the 1508 identiﬁed proteins (56%
of total proteins) were assigned to at least one of these three cate-
gories. The major molecular functions correlated with the identi-
ﬁed proteins were related to protein, RNA, and nucleotide bind-
ing, while among the involved pathways, the metabolic pathways
were predominant (Supporting Information B).
3.2. Quantitative Diﬀerential Expression and Classiﬁcation of
Proteins from 3T3-L1 Adipocyte Secretome in Hypoxia
In total, 109 identiﬁed proteins were diﬀerentially expressed (av-
erage fold change either > 2 or < 0.5) in the secretome from
3T3-L1 adipocytes following 24 h hypoxia. All proteins passing
the criteria of signiﬁcance and fold change were downregulated
(Supporting Information, Table 2), indicating that hypoxia plays
a regulatory role in the dynamic changes that aﬀect the adipocyte
secretome. Bioinformatic analysis revealed that more than 86%
(94 out of 109) of the downregulated proteins were classiﬁed as
belonging to either “extracellular region” (88 proteins) or “ex-
tracellular space” (69 proteins) (Supporting Information C). By
including proteins assigned to the category “extracellular exo-
somes„ the total number of downregulated proteins classiﬁed as
secreted was 108 (99%). Interestingly, the background of non-
secreted proteins, likely deriving from cell leakage, was much
higher when considering the entire set of the identiﬁed proteins.
In fact, proteins classiﬁed as either belonging to “extracellular re-
gion,” “extracellular space,” or “extracellular exosome” were 839
in total (56% of the 1508 identiﬁed proteins) (Supporting In-
formation B). The most prominent biological processes aﬀected
by hypoxia-induced protein downregulation were cell adhesion,
ECM organization, proteolysis, collagen ﬁbril organization, all of
which paradigmatic of a precocious remodeling of ECM in re-
sponse to hypoxia. Among the functions related to the identi-
ﬁed proteins, calcium and heparin binding were the most promi-
nent, while the main aﬀected pathways were related to ECM
receptor interaction, focal adhesion, and to the involvement of
the phospatidylinositol-3 kinase-AKT signaling (Supporting In-
formation C).
Notably, when compared with previous reports investigating
hypoxia-regulated proteins in the secretome from human SGBS
adipocytes[28] or in exosomes from 3T3-L1 adipocytes,[29] our
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Table 1. Diﬀerentially expressed proteins in the secretome from 3T3-L1 adipocytes in hypoxic/normoxic conditions.
Uniprot
accession
Gene Average fold
changea)
Extracellular
region
Extracellular
space
Extracellular
exosomes
↓ Proteins in
3T3-L1[29]
↓ Proteins in
SGBS[28]
Q61646 Hp 0.06 Yes Yes Yes
Q91XL1 Lrg1 0.09 Yes Yes
P03953 Cfd 0.13 Yes Yes Yes
P34928 Apoc1 0.14 Yes Yes
P01027 C3 0.17 Yes Yes Yes Yes
P11152 Lpl 0.18 Yes Yes Yes Yes
P47879 Igfbp4 0.18 Yes Yes
Q9R1Q9 Atp6ap1 0.19 Yes
E9QPB2 Sbsn 0.20 Yes Yes
P11859 Agt 0.21 Yes Yes
P70663 Sparcl1 0.21 Yes Yes Yes
Q9D7I0 Shisa5 0.21 Yes
Q9JK53 Prelp 0.21 Yes Yes Yes
Q99P87 Retn 0.22 Yes Yes Yes
Q07797 Lgals3bp 0.23 Yes Yes Yes Yes
A0A0N4SVV4 Rarres2 0.24 Yes Yes
P08121 Col3a1 0.24 Yes Yes Yes
P08226 Apoe 0.24 Yes Yes Yes Yes
Q01149 Col1a2 0.24 Yes Yes Yes Yes Yes
Q06890 Clu 0.24 Yes Yes Yes
Q61581 Igfbp7 0.24 Yes Yes Yes
Q8R2G6 Ccdc80 0.24 Yes
P11087 Col1a1 0.25 Yes Yes Yes Yes
P21460 Cst3 0.25 Yes Yes Yes Yes
Q61398 Pcolce 0.25 Yes Yes Yes Yes
Q9DD06 Rarres2 0.25 Yes Yes
P28653 Bgn 0.26 Yes Yes
Q03350 Thbs2 0.26 Yes
Q60994 Adipoq 0.26 Yes Yes Yes
G3 × 9T8 Cp 0.27 Yes Yes Yes
P07214 Sparc 0.27 Yes Yes Yes
Q04857 Col6a1 0.27 Yes Yes Yes Yes
Q62000 Ogn 0.27 Yes Yes Yes
Q8BND5 Qsox1 0.27 Yes Yes Yes
Q9R1E6 Enpp2 0.27 Yes Yes
O09164 Sod3 0.28 Yes Yes Yes
P55065 Pltp 0.28 Yes Yes
Q02788 Col6a2 0.28 Yes Yes Yes Yes Yes
Q9EPL2 Clstn1 0.28 Yes Yes
O88207 Col5a1 0.29 Yes Yes Yes
P07759 Serpina3n 0.29 Yes Yes Yes
P51910 Apod 0.29 Yes Yes Yes
Q9QZZ6 Dpt 0.29 Yes Yes Yes
A2AVA0 Svep1 0.30 Yes
P06909 Cfh 0.30 Yes Yes Yes
P43025 Clec3b 0.30 Yes Yes Yes
P10605 Ctsb 0.31 Yes Yes Yes Yes
Q07235 Serpine2 0.31 Yes Yes
(Continued)
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Table 1. Continued.
Uniprot
accession
Gene Average fold
changea)
Extracellular
region
Extracellular
space
Extracellular
exosomes
↓ Proteins in
3T3-L1[29]
↓ Proteins in
SGBS[28]
Q3UQ28 Pxdn 0.31 Yes Yes Yes
E9PWQ3 Col6a3 0.32 Yes Yes Yes
P97298 Serpinf1 0.32 Yes Yes Yes Yes
Q99K41 Emilin1 0.32 Yes Yes Yes
Q9JM58 Crlf1 0.32 Yes
P01029 C4b 0.33 Yes Yes Yes
P01887 B2m 0.33 Yes Yes Yes
P02463 Col4a1 0.33 Yes Yes
P08122 Col4a2 0.33 Yes Yes
P97873 Loxl1 0.33 Yes Yes
Q61554 Fbn1 0.33 Yes Yes Yes Yes
Q9WVJ9 Efemp2 0.33 Yes Yes
P28654 Dcn 0.34 Yes Yes
Q02853 Mmp11 0.34 Yes
Q3U962 Col5a2 0.34 Yes Yes
Q61112 Sdf4 0.34 Yes
Q62356 Fstl1 0.34 Yes Yes Yes
Q8QZR4 Oaf 0.34 Yes
Q62009 Postn 0.35 Yes Yes
J3QQ16 Col6a3 0.36 Yes Yes Yes
O08538 Angpt1 0.36 Yes Yes Yes
P51885 Lum 0.36 Yes Yes Yes Yes
Q08879 Fbln1 0.36 Yes Yes Yes
Q8CG16 C1ra 0.36 Yes Yes
P30412 Ppic 0.37 Yes
Q8BS97 Vcan 0.37 Yes Yes
Q8CG14 C1s1;C1sa;C1sb 0.37 Yes Yes
Q9WVH9 Fbln5 0.37 Yes Yes Yes
P10493 Nid1 0.38 Yes Yes Yes
P25785 Timp2 0.38 Yes Yes Yes
Q61207 Psap 0.38 Yes Yes Yes
Q9R0E1 Plod3 0.39 Yes
P33434 Mmp2 0.40 Yes Yes Yes
O88393 Tgfbr3 0.41 Yes Yes Yes
P35564 Canx 0.41 Yes
P11276 Fn1 0.42 Yes Yes Yes Yes Yes
Q00493 Cpe 0.42 Yes Yes Yes
Q06335 Aplp2 0.42 Yes
Q9WVB4 Slit3 0.42 Yes Yes
P12023 App 0.43 Yes Yes
P28301 Lox 0.43 Yes Yes
Q61508 Ecm1 0.43 Yes Yes Yes
Q62165 Dag1 0.43 Yes Yes Yes
P35441 Thbs1 0.44 Yes Yes Yes Yes
P97857 Adamts1 0.44 Yes
Q02819 Nucb1 0.44 Yes Yes Yes
Q60648 Gm2a 0.44 Yes
Q9R0E2 Plod1 0.44 Yes
O08746 Matn2 0.45 Yes
(Continued)
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Table 1. Continued.
Uniprot
accession
Gene Average fold
changea)
Extracellular
region
Extracellular
space
Extracellular
exosomes
↓ Proteins in
3T3-L1[29]
↓ Proteins in
SGBS[28]
Q9CQF9 Pcyox1 0.45 Yes
E9PZ16 Hspg2 0.46 Yes Yes Yes Yes
P16675 Ctsa 0.46 Yes
P37889 Fbln2 0.46 Yes Yes
P48759 Ptx3 0.46 Yes Yes
Q9JJH1 Rnase4 0.46 Yes Yes
Q9WVJ3 Cpq 0.46 Yes Yes Yes
P70699 Gaa 0.48 Yes
Q99JI6 Rap1b;Rap1a 0.48 Yes
O08992 Sdcbp 0.49 Yes Yes Yes Yes
P06797 Ctsl 0.49 Yes Yes
a) Fold change <1 indicates downregulation in hypoxic conditions.
Bold refers to newly identiﬁed regulated proteins, as compared with two previous reports in 3T3-L1[29] and SGBS[28] adipocytes.
Table 2. Diﬀerentially expressed proteins in the secretome from 3T3-L1 adipocytes as veriﬁed by Western blot (WB) analysis.
Accession Protein description Gene name Peptides Average fold changea) p WB
Q60994 Adiponectin Adipoq 11 0.26 0.00 Conﬁrmed
P35441;
Q80YQ1
Thrombospondin-1 Thbs1 33 0.44 0.01 Conﬁrmed
Q03350 Thrombospondin-2 Thbs2 29 0.26 0.00 Conﬁrmed
Q02853 Stromelysin-3 Mmp11 2 0.34 0.01 Conﬁrmed
a) Fold change <1 indicates downregulation in hypoxic conditions.
ﬁndings showed that of the 108 secreted, diﬀerentially expressed
identiﬁed proteins, 28 had been previously detected in at least one
of the above-mentioned studies, whereas 80 (74%) were newly
identiﬁed, regulated proteins (Table 1).
3.3. Western Blots and Gene Expression Studies Relative to
Candidate Proteins in 3T3-L1 Cells
Among the 109 diﬀerentially expressed proteins emerged from
LC-MS/MS experiments, candidates were selected for further val-
idation byWB analyses (Table 2) and subsequent gene expression
studies. Selection criteria for candidate proteins have considered
the potential functional signiﬁcance of the identiﬁed proteins in
the context of obesity-related disorders, our availability of speciﬁc
antibodies, and the lack of data about diﬀerential expression in-
duced by hypoxia for many proteins.
Therefore, adiponectin, thrombospondin-1 (THBS1) and -2
(THBS2), as well as matrix metalloproteinase 11 (MMP-11, also
known as stromelysin-3) were chosen among the downregulated
proteins. WB analysis conﬁrmed results obtained in LC-MS/MS
experiments (Table 2 and Figure 2), as all the four proteins tested
were shown to be downregulated in hypoxia. In hypoxic versus
normoxic 3T3-L1 cells, the decrease in adiponectin, THBS1 and
THBS2 protein species was conﬁrmed by q-RT PCR analysis of
the respective mRNAs, while MMP-11 gene expression was up-
regulated in hypoxia (Figure 2).
3.4. Gene Expression Studies Relative to Candidate Proteins in
Obese Versus Lean Mice
To investigate whether gene expression ﬁndings obtained in
vitro, in diﬀerentiated 3T3-L1 cells, were replicated in vivo, we
compared results from gene expression studies in fat tissue from
obese versus lean mice. As expected, in fat specimen from obese
mice, a higher detectable expression of HIF-1α was observed,
thereby conﬁrming ATH, that was compatible with the excess
of body weight in these animals (Supporting Information A,
Figure S1). Diﬀerences in gene expression between hypoxic ver-
sus normoxic fat tissues (Figure 3) paralleled ﬁndings obtained
in vitro, in 3T3-L1 adipocytes, only to a certain extent. This dis-
crepancy may account for the complex functional interactions of
the diﬀerent cells within fat tissue, and/or for systemic eﬀects.
4. Discussion
Hypoxia is considered an important trigger of changes that oc-
cur in the adipose tissue during obesity. In this work, we com-
prehensively proﬁled, under normoxic and hypoxic conditions,
the secretome of murine diﬀerentiated 3T3-L1 adipose cells, a
well-characterized cell line widely used in studies of adipose
cell biology. Proteomic analysis identiﬁed 109 diﬀerentially ex-
pressed proteins, all of which were downregulated by hypoxia.
This peculiar ﬁnding can be explained by the inhibitory eﬀects of
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Figure 2. Protein and gene expression results of the hypoxia-regulated selected factors in 3T3-L1 adipocytes. Cells were incubated under normoxia or
hypoxia for 24 h. TCA- precipitated secretome proteins were analyzed by WBs (upper), whereas q-RT PCRs (lower) were performed contextually, from
cells under the same experimental conditions. Data are means± SEM from at least three separate experiments. Densitometric analysis of WBs is shown
in bar graphs. Data are expressed as arbitrary units, with normoxia = 1 in each assay. Representative WBs are shown. *p < 0.05 versus normoxia, **p
< 0.001 versus normoxia.
hypoxia on protein synthesis, as already stated elsewhere.[28]
When compared with previous similar reports,[28,29] we identiﬁed
80 novel secreted proteins, that were downregulated in hypoxic
conditions. Possible explanations for the discrepancy between
our results and those from similar works could be: i) the broader
proteome coverage obtained by the newer-generation instrumen-
tation used in this study; ii) the stringent criteria adopted in our
analysis for the deﬁnition of hypoxia-regulated proteins; iii) the
high prevalence, among the regulated proteins, of truly secreted
proteins; iv) diﬀerences between cell models (human vs. murine
adipose cells). Most of these considerations, indeed, represent an
added value of this work. Bioinformatic analysis of the hypoxia-
induced diﬀerentially expressed proteins have shown that follow-
ing hypoxia, 3T3-L1 adipocytes precociously respond by reorga-
nizing and remodeling ECM. These results integrate and are in
line with previous ﬁndings obtained in transgenic animalmodels
expressing HIF-1α,[18] and in proteomic studies using the HIF-
1α chemical inducer, CoCl2, in human SGBS pre- and adipose
cells,[28] both of which underlie the role of ECM reorganization
in the early events linked to ATH.
Among the downregulated proteins, we identiﬁed and
further analyzed adiponectin, THBS1, THBS2, and MMP-11.
Adiponectin, THBS1, THBS2, but not MMP-11 had been pre-
viously identiﬁed in human adipocyte secretome by proteomic
strategies.[28] However, with the exception of THBS1,[29] none
of these proteins had been described as diﬀerentially regulated
by hypoxia by using similar approaches. Adiponectin is well
known to regulate glucose levels and fat metabolism, and
to play a role in insulin sensitivity. Its reduction has been
described in obesity, type 2 diabetes, and atherosclerosis.[39]
THBS1 and THBS2 are trimeric, multifunctional proteins, that
Figure 3. Gene expression studies (q-RT-PCR) of the hypoxia-regulated se-
lected factors in epididymal fat from obese versus lean mice (n = 4 and
5, respectively). Data are from three separate assays and expressed as ar-
bitrary units, with data from controls (lean) = 1 in each group. *p < 0.05,
**p < 0.001.
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inﬂuence cell-matrix interactions, and are diﬀerently expressed
in various tissues. Unlike other proteins with a prominent struc-
tural role in ECM, these matricellular molecules bind speciﬁc
membrane receptors, including CD36, CD47, and integrins,
as well as cytokines, growth factors, and proteases.[40] Their
functions include anti-angiogenic and wound healing eﬀects,
cell proliferation and diﬀerentiation, immune regulation, and
activation of TGF-β. THBS1 has been reported to be expressed
in adipose tissue, and to play a role in adipogenesis, although
the knock-out of the relative gene in mice does not alter adi-
pose tissue abundance, distribution, and vascularization.[41] In
vitro studies have documented that THBS1 is downregulated
by hypoxia in mouse embryonic ﬁbroblasts.[42] However, the
complexity of the interactions and tissue-speciﬁc expression of
its receptors may account for the paradox of opposed eﬀects de-
scribed in the literature. THBS2 knockdown has been associated
with abnormal collagen ﬁbrillogenesis, and increased levels of
pericellular metalloproteinase 2. MMP-11 belongs to the family
of matrix metalloproteinases and its role in ECM remodeling
is not well known, while its involvement in cancer progression
has been demonstrated. We recently explored the expression of
this protein in 3T3-L1 cells and in fat tissue from mice under
low or high-fat diet, showing that this protein is overexpressed
in insulin resistance.[43]
Altogether, the decreased expression of the above identiﬁed
proteins by hypoxic adipose cells coherently leads to ECM remod-
eling. In this respect, it is intriguing that adipose tissue, being
the main energy-storing compartment, has the unique peculiar-
ity to naturally expand, without cell transformation, until oxygen
diﬀusion limits, and this biological behavior is remarkably simi-
lar to solid tumor growth.[44] Discrepancies between in vitro and
in vivo ﬁndings reported in this study may have several explana-
tions, including the complexity of fat tissue cellular composition
and molecular networks, and the persistent hypoxic conditions,
that may implicate diﬀerent adaptive responses.
Although the biology of murine and human obesity presents
important diﬀerences, and whether rodent models ﬁt for re-
search of human obesity and related disorders remain a ques-
tionable issue,[45] 3T3-L1 adipose cells still represent a valuable
tool to investigate obesity-related disorders. On the other hand,
experiments in cell lines represent an oversimpliﬁcation of what
occurs in vivo, in whole animals, although they are often needed
to establish “proof of principle.” In this context, future studies
may be undertaken to explore the role of the newly identiﬁed,
hypoxia-regulated proteins and their link to adipose cell dysfunc-
tion in obesity.
We believe that, by providing information about the dynamic
changes that occur in the adipocyte secretome in hypoxia, we
may improve our knowledge about the pathophysiological events
characterizing the transition to the obese state, as well as iden-
tify new biomarkers and/or therapeutic targets that could be
searched for in obesity.
Supporting Information
Supporting Information is available from the Wiley Online Library or from
the author.
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